![Top 20 biopharmaceutical companies hold their spot despite market cap drop in Q1 2022 - Pharmaceutical Technology Top 20 biopharmaceutical companies hold their spot despite market cap drop in Q1 2022 - Pharmaceutical Technology](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2022/05/globsl.png)
Top 20 biopharmaceutical companies hold their spot despite market cap drop in Q1 2022 - Pharmaceutical Technology
Buy Moderna and BioNTech Stock. Both Pharmas Have Strong Drug Pipelines and Plenty of Cash. - Barrons
![Top 20 global biopharmaceutical companies by market capitalization (quarter ended March 31, 2022), presented by GlobalData - GlobalData Top 20 global biopharmaceutical companies by market capitalization (quarter ended March 31, 2022), presented by GlobalData - GlobalData](https://eu.vocuspr.com/Publish/3434416/vcsPRAsset_3434416_152867_e4c0333c-75ea-4f1c-980f-89a5fd811bc4_0.png)
Top 20 global biopharmaceutical companies by market capitalization (quarter ended March 31, 2022), presented by GlobalData - GlobalData
![Market cap growth surges for over half of the top biopharmaceutical companies in 2022 - Pharmaceutical Technology Market cap growth surges for over half of the top biopharmaceutical companies in 2022 - Pharmaceutical Technology](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2023/02/New-table.jpg)
Market cap growth surges for over half of the top biopharmaceutical companies in 2022 - Pharmaceutical Technology
![Covid-19 drug biopharmaceutical companies outperform with market cap growth in 2021 - Clinical Trials Arena Covid-19 drug biopharmaceutical companies outperform with market cap growth in 2021 - Clinical Trials Arena](https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2022/01/covid-vaccine-graph4.jpg)